Details for Patent: 9,211,282
✉ Email this page to a colleague
Which drugs does patent 9,211,282 protect, and when does it expire?
Patent 9,211,282 protects TOSYMRA and is included in one NDA.
This patent has sixteen patent family members in thirteen countries.
Summary for Patent: 9,211,282
Title: | Formulations comprising triptan compounds |
Abstract: | The invention provides a pharmaceutical composition for intranasal administration comprising a salt of sumatriptan or a physiologically acceptable solvate thereof, an alkyl glycoside or saccharide alkyl ester and optionally at least one pharmaceutically acceptable excipient, wherein the said composition provides T.sub.max value of less than 30 minutes upon said administration. Other aspects and embodiments are contemplated and described. The invention also provides a pharmaceutical composition for intranasal administration comprising a triptan, a pharmaceutically acceptable vehicle and a mucosal permeation enhancer, wherein upon said administration said composition provides a T.sub.max substantially equivalent to subcutaneous administration of said triptan. Other aspects and embodiments are contemplated and described. |
Inventor(s): | Gandhi; Rajesh (Sagar, IN), Manikonda; Sreekanth (Visakhapatnam, IN), Jana; Arun (Panna, IN), Kunte; Sameer Shrinivas (Mumbai, IN) |
Assignee: | DR. REDDY'S LABORATORIES LTD. (Hyderabad, IN) |
Application Number: | 12/817,740 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,211,282
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ACUTE TREATMENT OF MIGRAINE | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,211,282
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
India | 2337/CHE/2009 | Sep 25, 2009 |
India | 2607/CHE/2009 | Oct 27, 2009 |
International Family Members for US Patent 9,211,282
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010299607 | ⤷ Try a Trial | |||
Canada | 2775404 | ⤷ Try a Trial | |||
China | 102933198 | ⤷ Try a Trial | |||
Denmark | 2480197 | ⤷ Try a Trial | |||
European Patent Office | 2480197 | ⤷ Try a Trial | |||
Spain | 2553862 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |